Evaluation the auxiliary diagnosis value of antibodies assays for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19)
Detection Principle
ImmunoAssay-Antibody
Target
IgM/IgG
Testing Method Category
Testing Method
GICA individual-kit
Testing Method - Additional Info
Kit: Innovita Biological Technolog
Reported Performance
Sensitivity: 23.0% (IgM, 0-8 dpo), 53.8% (IgG, 0-8 dpo), 50.0% (IgM, 8-15 dpo), 92.1% (IgG, 8-15 dpo), 52.2% (IgM, 15+ dpo), 91.3% (IgG, 15+ dpo)
Sample Size
38 patients
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements